Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results Pharmaceutical Investing
Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC 2022 Highlights Pharmaceutical Investing
Cardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II Clinical Trial of CardiolRx for Treatment of Acute Myocarditis Pharmaceutical Investing
